Pfizer pins hopes on daily pill to crack market for weight-loss drugs
Pharma group seeks to catch up with rivals Eli Lilly and Novo Nordisk in sector projected to be worth $130bn a year
版權(quán)聲明：本文版權(quán)歸FT中文網(wǎng)所有，未經(jīng)允許任何單位或個人不得轉(zhuǎn)載，復制或以任何其他方式使用本文全部或部分，侵權(quán)必究。